New rabies vaccine trial aims to save lives with stronger protection
NCT ID NCT07500207
First seen Apr 07, 2026 · Last updated Jun 14, 2026 · Updated 9 times
Summary
This study tests a new rabies vaccine in 3,000 healthy people aged 10 to 60. The goal is to see how well it triggers the body's defenses and if it's safe. The vaccine is given in different schedules to find the best way to prevent rabies after a possible exposure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES PREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
sichuan CDC
Neijiang, Sichuan, China
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.